Academic Report by Professor Jindrich Henry Kopecek from the National Academy of Engineering at Our Invitation
In order to promote a deeper understanding of the discipline development frontier and international academic exchange, Prof. Zhou Jianping, Director of the Department of Pharmaceutics, School of Pharmacy, invited Prof. Kopecek from the University of Utah to come to our university for an academic report titled “Design of Smart Polymeric Nanomedicines”.
In the lecture, Prof. Kopecek introduced his research achievements in simple language. Prof. Kopecek designed and prepared a new generation of water-soluble drug carrier - poly (N-hydroxypropylmethacrylamide) (PolyHPMA), and took the lead in the introduction into anticancer macromolecules drug therapy, which not only created related research on controlled release polymer drug system, but also put the long-acting targeted composite formulations (including doxorubicin) into clinical trial for the first time. During the lecture, the participating teachers and students actively engaged in interactive questions with Prof. Kopecek, with a warm atmosphere and remarkable results.
Dr. Kopecek is a distinguished professor of Pharmaceutics and Medicinal Chemistry of the Department of Bioengineering and School of Pharmacy, University of Utah, USA, and a member of the National Academy of Engineering. He served as Chairman of the Department of Biomaterials and Biology Interfaces of National Institutes of Health (NIH) and is involved in decision-making of funding research projects. In the past 30 years, Prof. Kopecek has received a total of 22.6 million U.S. dollars from NIH and industry projects, whose research has a very high impact in related fields. Dr. Kopecek has published more than 440 papers in the international core journals such as Nature, Nature Biotechnology, Angew. Chem. Int. Ed., and Biomaterials, which have been cited for more than 25,436 times with a Hirsh Index of 85. As an international leading figure in the field of controlled release drugs and a pioneer in the research of targeted anti-cancer agents, Prof. Kopecek served as President of the International Institute of Controlled Release (1995-1996) and was awarded the Founder Award (1999) by the International Institute of Controlled Release, Millennium Achievement Award for Pharmacologists (2000) from the Millennium World Pharmacy Conference, International Award for Excellence in Science by the Japan Society for Biomaterials (2006), Lifetime Achievement Award (2011) by the Journal of Drug Targeting, and so on. In 2014, Prof. Kopecek was awarded an honorary doctorate by the University of Helsinki, Finland.